America August 28, 2025
DOJ Urges Fresh Review in J&J $1.6B FCA Lifeline Case
The U.S. Department of Justice has thrown a curveball into Johnson & Johnson’s high-stakes False Claims Act battle, telling the…
America August 28, 2025
The U.S. Department of Justice has thrown a curveball into Johnson & Johnson’s high-stakes False Claims Act battle, telling the…
By Rihem Akkouche
America August 29, 2023
In a significant move bound to ripple through the healthcare landscape, the U.S. Department of Health and Human Services (HHS)…
By Rihem Akkouche
Business August 20, 2020
Johnson & Johnson (NYSE: JNJ) announced its decision to acquire Momenta Pharmaceuticals (NASDA: MNTA) for $6.5 billion in an all-cash…
By Marivic Cabural Summers